240 related articles for article (PubMed ID: 9631649)
1. Eukaryotic DNA topoisomerase II beta.
Austin CA; Marsh KL
Bioessays; 1998 Mar; 20(3):215-26. PubMed ID: 9631649
[TBL] [Abstract][Full Text] [Related]
2. Functional compatibility between isoform alpha and beta of type II DNA topoisomerase.
Sakaguchi A; Kikuchi A
J Cell Sci; 2004 Mar; 117(Pt 7):1047-54. PubMed ID: 14996935
[TBL] [Abstract][Full Text] [Related]
3. Two COOH-terminal truncated cytoplasmic forms of topoisomerase II alpha in a VP-16-selected lung cancer cell line result from partial gene deletion and alternative splicing.
Yu Q; Mirski SE; Sparks KE; Cole SP
Biochemistry; 1997 May; 36(19):5868-77. PubMed ID: 9153428
[TBL] [Abstract][Full Text] [Related]
4. C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo.
Linka RM; Porter AC; Volkov A; Mielke C; Boege F; Christensen MO
Nucleic Acids Res; 2007; 35(11):3810-22. PubMed ID: 17526531
[TBL] [Abstract][Full Text] [Related]
5. Increased sensitivity to quinolone antibacterials can be engineered in human topoisomerase IIalpha by selective mutagenesis.
Hammonds TR; Foster SR; Maxwell A
J Mol Biol; 2000 Jul; 300(3):481-91. PubMed ID: 10884345
[TBL] [Abstract][Full Text] [Related]
6. Both alpha and beta isoforms of mammalian DNA topoisomerase II associate with chromosomes in mitosis.
Null AP; Hudson J; Gorbsky GJ
Cell Growth Differ; 2002 Jul; 13(7):325-33. PubMed ID: 12133901
[TBL] [Abstract][Full Text] [Related]
7. Characterization of DNA topoisomerase II alpha/beta heterodimers in HeLa cells.
Gromova I; Biersack H; Jensen S; Nielsen OF; Westergaard O; Andersen AH
Biochemistry; 1998 Nov; 37(47):16645-52. PubMed ID: 9843432
[TBL] [Abstract][Full Text] [Related]
8. Catalytic function of DNA topoisomerase II.
Osheroff N; Zechiedrich EL; Gale KC
Bioessays; 1991 Jun; 13(6):269-73. PubMed ID: 1654050
[TBL] [Abstract][Full Text] [Related]
9. Conjugation of human topoisomerase 2 alpha with small ubiquitin-like modifiers 2/3 in response to topoisomerase inhibitors: cell cycle stage and chromosome domain specificity.
Agostinho M; Santos V; Ferreira F; Costa R; Cardoso J; Pinheiro I; Rino J; Jaffray E; Hay RT; Ferreira J
Cancer Res; 2008 Apr; 68(7):2409-18. PubMed ID: 18381449
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
Lok CN; Lang AJ; Mirski SE; Cole SP
Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
[TBL] [Abstract][Full Text] [Related]
11. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the ATPase activity of topoisomerase II from Leishmania donovani and identification of residues conferring resistance to etoposide.
Sengupta T; Mukherjee M; Das A; Mandal C; Das R; Mukherjee T; Majumder HK
Biochem J; 2005 Sep; 390(Pt 2):419-26. PubMed ID: 15901238
[TBL] [Abstract][Full Text] [Related]
13. Chlorella virus Marburg topoisomerase II: high DNA cleavage activity as a characteristic of Chlorella virus type II enzymes.
Dickey JS; Choi TJ; Van Etten JL; Osheroff N
Biochemistry; 2005 Mar; 44(10):3899-908. PubMed ID: 15751965
[TBL] [Abstract][Full Text] [Related]
14. An atypical topoisomerase II from Archaea with implications for meiotic recombination.
Bergerat A; de Massy B; Gadelle D; Varoutas PC; Nicolas A; Forterre P
Nature; 1997 Mar; 386(6623):414-7. PubMed ID: 9121560
[TBL] [Abstract][Full Text] [Related]
15. A distinct subnuclear localization of mammalian DNA topoisomerase IIbeta in yeast.
Sakaguchi A; Akashi T; Kikuchi A
Biochem Biophys Res Commun; 2001 May; 283(4):876-82. PubMed ID: 11350066
[TBL] [Abstract][Full Text] [Related]
16. Differences in the longevity of topo IIalpha and topo IIbeta drug-stabilized cleavable complexes and the relationship to drug sensitivity.
Errington F; Willmore E; Leontiou C; Tilby MJ; Austin CA
Cancer Chemother Pharmacol; 2004 Feb; 53(2):155-62. PubMed ID: 14504921
[TBL] [Abstract][Full Text] [Related]
17. A biochemical analysis of topoisomerase II alpha and beta kinase activity found in HIV-1 infected cells and virus.
Kondapi AK; Padmaja G; Satyanarayana N; Mukhopadyaya R; Reitz MS
Arch Biochem Biophys; 2005 Sep; 441(1):41-55. PubMed ID: 16091284
[TBL] [Abstract][Full Text] [Related]
18. Regulation of topoisomerase II alpha and beta in HIV-1 infected and uninfected neuroblastoma and astrocytoma cells: involvement of distinct nordihydroguaretic acid sensitive inflammatory pathways.
Mandraju RK; Kondapi AK
Arch Biochem Biophys; 2007 May; 461(1):40-9. PubMed ID: 17391642
[TBL] [Abstract][Full Text] [Related]
19. Mutation P732L in human DNA topoisomerase IIbeta abolishes DNA cleavage in the presence of calcium and confers drug resistance.
Leontiou C; Lakey JH; Lightowlers R; Turnbull RM; Austin CA
Mol Pharmacol; 2006 Jan; 69(1):130-9. PubMed ID: 16239602
[TBL] [Abstract][Full Text] [Related]
20. A study of the topoisomerase II activity in HIV-1 replication using the ferrocene derivatives as probes.
Kondapi AK; Satyanarayana N; Saikrishna AD
Arch Biochem Biophys; 2006 Jun; 450(2):123-32. PubMed ID: 16712776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]